investorrelations@financiere-tubize.be
© 2023 FINANCIÈRE DE TUBIZE S.A.




Home › Our societal commitment

Our societal commitment

In 2025, Financière de Tubize, together with the Pulse Foundation, opted to grant €50,000 to two start-ups that focus on improving health access.

The family values that drive us naturally lead us to a strong societal commitment.

Our societal commitment is based on several pillars:

  • The stability of a long-term reference shareholder base, enabling UCB to make its own societal contribution to the ecosystem of which it is a part (generating jobs, developing R&D skills, attracting talent, supporting local communities, etc.).
  • The influence of our four representatives on UCB’s Board of Directors as regards defining, monitoring and evaluating UCB’s societal ambitions.
  • Investing in initiatives with a high societal impact that enable disadvantaged populations or those with limited access to healthcare to live longer, healthier lives. In 2024, we collaborated with the Pulse Foundation to develop a project to foster the emergence and acceleration of innovations that improve access to healthcare for as many people as possible. The Pulse Foundation launched the call for projects in 2025 and more than 20 candidates submitted their applications. The jury met last December and chose two winners who will each benefit from a support of € 50,000 and coaching tailored to their specific needs.
  • The support of certain organisations dedicated to promoting/defending the interests of the biopharma ecosystem in Belgium and possibly in other geographical areas relevant to UCB.

As a committed reference shareholder of UCB, we attach great importance to the presence of high-performance biopharma ecosystems in Belgium and in geographical areas relevant to UCB.

We focus in particular on the following aspects:

  • The support of educational institutions and universities with programmes tailored to the specific needs of the biopharma industry near our operational sites. For research to be successful, it is necessary to find, attract and develop world class talent with the right skills.
  • The promotion of the international mobility of talent (and their families) to these regions so that they can share their know-how and thus accelerate innovation within the local biopharma ecosystem.
  • Interactions with the public authorities in these countries to encourage them to create an environment conducive to research and development in the biopharma ecosystem and to promote investments in the sector.

The family values that drive us naturally lead us to a strong societal commitment.

Our societal commitment is based on several pillars:

  • The stability of a long-term reference shareholder base, enabling UCB to make its own societal contribution to the ecosystem of which it is a part (generating jobs, developing R&D skills, attracting talent, supporting local communities, etc.).
  • The influence of our four representatives on UCB’s Board of Directors as regards defining, monitoring and evaluating UCB’s societal ambitions.
  • Investing in initiatives with a high societal impact that enable disadvantaged populations or those with limited access to healthcare to live longer, healthier lives. In 2024, we collaborated with the Pulse Foundation to develop a project to foster the emergence and acceleration of innovations that improve access to healthcare for as many people as possible. The Pulse Foundation launched the call for projects in 2025 and more than 20 candidates submitted their applications. The jury met last December and chose two winners who will each benefit from a support of € 50,000 and coaching tailored to their specific needs.
  • The support of certain organisations dedicated to promoting/defending the interests of the biopharma ecosystem in Belgium and possibly in other geographical areas relevant to UCB.

As a committed reference shareholder of UCB, we attach great importance to the presence of high-performance biopharma ecosystems in Belgium and in geographical areas relevant to UCB.

We focus in particular on the following aspects:

  • The support of educational institutions and universities with programmes tailored to the specific needs of the biopharma industry near our operational sites. For research to be successful, it is necessary to find, attract and develop world class talent with the right skills.
  • The promotion of the international mobility of talent (and their families) to these regions so that they can share their know-how and thus accelerate innovation within the local biopharma ecosystem.
  • Interactions with the public authorities in these countries to encourage them to create an environment conducive to research and development in the biopharma ecosystem and to promote investments in the sector.